CSF sPDGFRβ levels were elevated in MCI17 and AD16 and correlated with CSF total tau (t‐tau) and p‐tau levels 16, 17, 18, 22 and Qalb18, 19 across the AD spectrum. The gene discussed is MAPT; the disease is Alzheimer disease.